Using Data for Public Good
The Immune Tolerance Network’s (ITN) TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge. The theme of this year’s competition was “Using Data for the Public Good.”
The ITN is a research cooperative led by Benaroya Research Institute at Virginia Mason (BRI) and funded by a grant from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).
The ITN’s entry, entitled “ITN TrialShare: Enabling True Clinical Trial Transparency,” describes the unique data sharing portal developed by the Network. The system provides clinical trial investigators an unprecedented ability to share data with other researchers. Among its unique features are the ability to access raw de-identified participant level study data, review published analysis methods, and perform real-time interactive graphical analyses in collaboration with other researchers.
You Might Also Like
Understanding the Immune System’s Brakes
Explore work from Daniel Campbell, PhD, examining how a cytokine called IL2 could lead to new therapies for autoimmune diseases.
Innovation Fund Backs Exciting New Research
Allyson Byrd, PhD, and Cate Speake, PhD, are exploring an innovative tool in immunology research. The questions they can ask are limitless.
Working Toward Cures
Did you know that if risk screening results show you are in the early stages of T1D, you may be eligible to participate in a type 1 diabetes prevention study?
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.